Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-12-018975
Filing Date
2012-03-30
Accepted
2012-03-30 16:55:21
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v307184_10k.htm 10-K 897500
2 EXHIBIT 31.1 v307184_ex31-1.htm EX-31.1 7522
3 EXHIBIT 31.2 v307184_ex31-2.htm EX-31.2 7231
4 EXHIBIT 32.1 v307184_ex32-1.htm EX-32.1 4050
5 EXHIBIT 32.2 v307184_ex32-2.htm EX-32.2 3912
  Complete submission text file 0001144204-12-018975.txt   2992803

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arni-20111231.xml EX-101.INS 307515
7 XBRL TAXONOMY EXTENSION SCHEMA arni-20111231.xsd EX-101.SCH 18842
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arni-20111231_cal.xml EX-101.CAL 38627
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arni-20111231_def.xml EX-101.DEF 116718
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arni-20111231_lab.xml EX-101.LAB 144754
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arni-20111231_pre.xml EX-101.PRE 138767
Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822 (862) 703-7175
Arno Therapeutics, Inc (Filer) CIK: 0001195116 (see all company filings)

EIN.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52153 | Film No.: 12730012
SIC: 2834 Pharmaceutical Preparations